The purpose of this study was to compare the effects of raising female Fischer rats on a low-fat, high-complex-carbohydrate diet (LFCC) versus a high-fat, sucrose diet (HFS) on serum glucose and insulin as well as skeletal muscle glucose transport. No significant differences were observed between 6- and 24-month-old rats raised on the LFCC diet for serum glucose (3.6 ± 0.1 vs. 3.7 ± 0.2 mM) and insulin (88 ± 6 vs. 98 ± 10 pM) or for basal (35 ± 3 vs. 39 ± 6 pmol/mg protein/15 s) or insulin-stimulated (74.2 ± 7.6 vs. 69.4 ± 3.8 pmol/mg protein/15 s) glucose transport. These data indicate that aging per se does not lead to insulin resistance. When the 24-month-old animals raised on the HFS diet were compared with those on the LFCC diet, major differences were observed. Fasting serum insulin was significantly higher in the HFS group (437 ± 118 vs. 98 ± 10 pM) and insulin-stimulated glucose transport was significantly reduced (52.5 ± 3.7 vs. 69.4 ± 3.8 pmol/mg protein/15 s). Fasting glucose (3.7 ± 0.2 vs. 3.6 ± 0.1 mM) and basal glucose transport (38 ± 6 vs. 39 ± 6 pmol/mg protein/15 s) were unchanged. These results indicate that diet and not aging per se caused insulin resistance.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.